Renaissance Technologies’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$463K Buy
+30,936
New +$463K ﹤0.01% 2873
2024
Q2
Sell
-49,468
Closed -$1.88M 3949
2024
Q1
$1.88M Buy
49,468
+932
+2% +$35.3K ﹤0.01% 2074
2023
Q4
$1.04M Buy
48,536
+25,307
+109% +$544K ﹤0.01% 2378
2023
Q3
$285K Buy
23,229
+7,509
+48% +$92.1K ﹤0.01% 2949
2023
Q2
$177K Buy
15,720
+8,476
+117% +$95.4K ﹤0.01% 3330
2023
Q1
$53K Buy
7,244
+1,200
+20% +$8.78K ﹤0.01% 3652
2022
Q4
$68K Sell
6,044
-3,948
-40% -$44.4K ﹤0.01% 3729
2022
Q3
$131K Sell
9,992
-13,306
-57% -$174K ﹤0.01% 3506
2022
Q2
$294K Buy
23,298
+17,223
+284% +$217K ﹤0.01% 3465
2022
Q1
$349K Sell
6,075
-3,853
-39% -$221K ﹤0.01% 3399
2021
Q4
$1.18M Buy
9,928
+5,916
+147% +$703K ﹤0.01% 2525
2021
Q3
$797K Buy
4,012
+1,981
+98% +$394K ﹤0.01% 2670
2021
Q2
$353K Buy
2,031
+1,611
+384% +$280K ﹤0.01% 3090
2021
Q1
$83K Sell
420
-1,548
-79% -$306K ﹤0.01% 3231
2020
Q4
$387K Sell
1,968
-11,922
-86% -$2.34M ﹤0.01% 2935
2020
Q3
$2.46M Sell
13,890
-8,272
-37% -$1.47M ﹤0.01% 2004
2020
Q2
$5.13M Sell
22,162
-1,824
-8% -$422K ﹤0.01% 1634
2020
Q1
$2.79M Buy
23,986
+950
+4% +$111K ﹤0.01% 1883
2019
Q4
$4.4M Buy
23,036
+608
+3% +$116K ﹤0.01% 1930
2019
Q3
$4.31M Buy
22,428
+628
+3% +$121K ﹤0.01% 1877
2019
Q2
$3.73M Buy
21,800
+3,648
+20% +$625K ﹤0.01% 1985
2019
Q1
$3.65M Sell
18,152
-108
-0.6% -$21.7K ﹤0.01% 2004
2018
Q4
$3.42M Sell
18,260
-430
-2% -$80.5K ﹤0.01% 1964
2018
Q3
$4.47M Sell
18,690
-2,438
-12% -$583K ﹤0.01% 1881
2018
Q2
$5.59M Buy
21,128
+17,048
+418% +$4.51M 0.01% 1716
2018
Q1
$1.01M Buy
4,080
+2,796
+218% +$694K ﹤0.01% 2659
2017
Q4
$174K Buy
1,284
+772
+151% +$105K ﹤0.01% 3160
2017
Q3
$63K Sell
512
-496
-49% -$61K ﹤0.01% 3118
2017
Q2
$97K Sell
1,008
-440
-30% -$42.3K ﹤0.01% 3087
2017
Q1
$270K Buy
+1,448
New +$270K ﹤0.01% 2934